The first annual report of the International Society for Heart and Lung Transplantation
(ISHLT) Mechanically Assisted Circulatory Support (IMACS) registry provides global data on …

Background In Japan, ventricular assist devices (VADs) have been used for patients with
severe heart failure as a bridge to transplantation (BTT) since 1992. However, it was not until …

Over the last 2 decades, mechanical circulatory support devices have been developed with
the goal of supporting patients with advanced heart failure as a bridge to cardiac …

The second annual IMACS registry report includes over 14, 000 patients from 35 countries.
Survival, adverse events, and an updated risk model is presented. Continuous flow pumps …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Background With primary funding and oversight provided by the NHLBI, the Interagency
Registry for Mechanically Assisted Circulatory Support (INTERMACS) was established to …

Background The Interagency Registry for Mechanically Assisted Circulatory Support
(Intermacs), a joint effort among the National Heart, Lung, and Blood Institute, the Food and …

Mechanical circulatory support (MCS) frequently is used to treat medically refractory end-
stage heart failure. Initially designed to be a bridge to transplantation, MCS also has proven …

After the REMATCH trial 1 and international consensus recommendations 2 on mechanical
circulatory support, the International Society for Heart and Lung Transplantation (ISHLT) …

BACKGROUND: The Interagency Registry for Mechanically Assisted Circulatory Support
(INTERMACS) is an NIH-sponsored registry of US FDA− approved mechanical circulatory …